Brian William Labadie

6PUBLICATIONS
74CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 12, 2026
Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTO.

|Sep 26, 2025
Spatially organized lymphocytic microenvironments in high grade primary prostate tumors.

Ali Amiryousefi, Jeremiah Wala, Jia-Ren Lin

|May 07, 2025
Phase II Study of Pexidartinib Plus Sirolimus in Unresectable Malignant Peripheral Nerve Sheath Tumors Identifies M2 Macrophage Activation.

Gulam A Manji, Liam J Stanton, Angela C Hirbe

|Sep 18, 2023
Suppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN/p53-deficient Aggressive-variant Prostate Cancer via Macrophage Phagocytosis.

Kiranj Chaudagar, Hanna M Hieromnimon, Anne Kelley

|Mar 02, 2023
Reversal of Lactate and PD-1-mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer.

Kiranj Chaudagar, Hanna M Hieromnimon, Rimpi Khurana

|May 04, 2021
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma.

Daniel J Olson, Zeynep Eroglu, Bruce Brockstein

Pageof 1

Frequent Collaborators

3 joint publications

Akash Patnaik

3 joint publications

Kiranj Chaudagar

2 joint publications

Anne Kelley

2 joint publications

Xiaobing Fan